EFFICACY AND SAFETY OF DOUBLE VS. STANDARD DOSE RECOMBINANT HEPATITIS B VACCINE IN INFANTS BORN TO HBSAG-POSITIVE MOTHERS:AN INTERIM REPORT OF A MULTI-CENTER, RANDOMIZED AND CONTROLLED TRIAL

被引：0
|
作者：
Duan, Zhongping [1 ]
Zou, Huaibin [1 ]
Chen, Yu [1 ]
Zhang, Hua [2 ]
Li, Yujie [3 ]
Dai, Erhei [4 ]
Liu, Zhongsheng [5 ]
Pan, Calvin [6 ]
机构：
[1] Capital Med Univ, Artificial Liver Ctr, Beijing YouAn Hosp, Beijing, Peoples R China
[2] Capital Med Univ, Dept Obstet & Gynecol, Beijing YouAn Hosp, Beijing, Peoples R China
[3] Taiyuan Infect Dis Hosp, Taiyuan, Peoples R China
[4] Shijiazhuang Fifth Hosp, Shijiazhuang, Peoples R China
[5] Tongliao Infect Dis Hosp, Tonglio, Peoples R China
[6] Mt Sinai Sch Med, Div Liver Dis, Flushing, NY USA
来源：
HEPATOLOGY | 2011年 / 54卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：884A / 885A
页数：2
相关论文
共 35 条
  • [31] Multi-center, double-blind, randomized, placebo-controlled phase II study to assess the efficacy of recombinant MAGE-A3 vaccine as adjuvant therapy in stage IB/II MADE-A3-positive, completely resected, non-small cell lung cancer (NSCLC).
    Vansteenkiste, J.
    Zielinski, M.
    Dahabre, J.
    Linder, A.
    Malinowski, W.
    Jassem, J.
    Lopez-Brea, M.
    Passlick, B.
    Lehmann, F.
    Brichard, V.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 368S - 368S
  • [32] A Phase 2b, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Dose-Finding, Multi-Center Study to Evaluate the Safety and Efficacy of ASP015K in Moderate to Severe Rheumatoid Arthritis Subjects Not on Concomitant Methotrexate.
    Genovese, Mark C.
    Greenwald, Maria
    Codding, Christine
    Cardiel, Mario H.
    Zubrzycka-Sienkiewicz, Anna
    Kivitz, Alan J.
    Wisseh, Steve
    Shay, Kathyjo
    Garg, Jay P.
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S1234 - S1235
  • [33] Efficacy and Safety of Docetaxel and Sodium Cantharidinate Combination vs. Either Agent Alone as Second-Line Treatment for Advanced/Metastatic NSCLC With Wild-Type or Unknown EGFR Status: An Open-Label, Randomized Controlled, Prospective, Multi-Center Phase III Trial (Cando-L1)
    Wu, Lin
    Deng, Chao
    Zhang, Hui
    Weng, Jie
    Wu, Youhua
    Zeng, Shan
    Tang, Tiegang
    Cao, Peiguo
    Qiu, Bo
    Zhang, Li
    Duan, Huaxin
    Zhang, Bing
    Zhang, Dong
    Zhang, Taotao
    Hu, Chunhong
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [34] A Phase 2b, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Dose-Finding, Multi-Center Study to Evaluate the Safety and Efficacy of ASP015K in Moderate to Severe Rheumatoid Arthritis Subjects Who Have Had an Inadequate Response to Methotrexate.
    Kivitz, Alan J.
    Zubrzycka-Sienkiewicz, Anna
    Gutierrez-Urena, Sergio R.
    Poiley, Jeffrey
    Kristy, Rita
    Shay, Kathyjo
    Garg, Jay P.
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S421 - S422
  • [35] KEVLAR: A phase 2b, multi-institutional, randomized, blinded, controlled trial to assess the safety and efficacy of two schedules of RRx-001 vs. standard of care in attenuating severe oral mucositis (SOM) in patients receiving concomitant chemoradiation (CRT) for the treatment of locally advanced squamous cell carcinomas (SCC) of the oral cavity (OC) or oropharynx (OPC)
    Reid, Tony R.
    Oronsky, Bryan
    Caroen, Scott
    Abrouk, Nacer
    Stirn, Meaghan
    Sonis, Stephen T.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
1234